| PERIOD ENDING | 30-Oct-09 | 31-Jul-09 | 1-May-09 | 30-Jan-09 | | Total Revenue | 394,733 | 361,486 | 359,502 | 309,717 | | Cost of Revenue | 264,781 | 244,339 | 246,904 | 207,565 | | | Gross Profit | 129,952 | 117,147 | 112,598 | 102,152 | | | Operating Expenses | | Research Development | 15,710 | 14,868 | 18,294 | 17,398 | | Selling General and Administrative | 73,562 | 51,966 | 62,347 | 59,725 | | Non Recurring | (7,946) | 7,946 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,596 | 42,367 | 31,957 | 25,029 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 685 | 168 | 5,384 | (4,603) | | Earnings Before Interest And Taxes | 49,311 | 42,535 | 37,341 | 20,426 | | Interest Expense | 7,319 | 7,024 | 7,610 | 6,736 | | Income Before Tax | 41,992 | 35,511 | 29,731 | 13,690 | | Income Tax Expense | 4,018 | 3,009 | 4,316 | 2,168 | | Minority Interest | (81) | (24) | (77) | (35) | | | | Net Income From Continuing Ops | 37,893 | 32,478 | 25,338 | 11,487 | | | Non-recurring Events | | Discontinued Operations | (3,392) | 163 | 375 | 15,456 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,501 | 32,641 | 25,713 | 26,943 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,501 | $32,641 | $25,713 | $26,943 |
|
1.52% Nasdaq 0.00%
Income Statement
